OFIX - Orthofix Medical Inc.
The average of price targets set by Wall Street analysts indicates a potential upside of 33.3% in Orthofix (OFIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial execution as adoption of Canopus by eXeX accelerates across hospital systems in the United States and United Kingdom, and as eXeX launches Canopus Command, the first portal to give hospital leadership a live operational view into step-by-step execution of every surgical case. ORLANDO, Fla.
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: Needham Virtual MedTech & Diagnostics 1x1 Conference - Virtual, August 10, 2026, 1x1 Meetings Canaccord Genuity's 46th Annual Growth Conference - Boston, August 12, 2026, Fireside Chat Time: 9:30 am Eastern Time Interested parties can access the live and archived webcast of the Canaccord Ge.
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referenc.
Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Orthofix Medical Inc. (OFIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5,
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
SHAREHOLDER ALERT: Purcell and Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX) PR Newsw
NEW YORK, May 26, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Orthofix Medical Inc. (NASDAQ: OFIX) on behalf of the company's shareholders. The investigation seeks to determine whether Orthofix Medical's directors breached their fiduciary duties in connection with recent corporate actions.
[url="]Orthofix Medical Inc[/url]. (NASDAQ: OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: Goldman Sachs 47th Annual Global Healthcare Conference - Miami Beach, June 8, 2026, Fireside Chat Time: 8:40 am Eastern Time Truist Securities MedTech Conference - Boston, June 16, 2026, 1x1 Meetings Only Interested parties can access the live and archived webcast of the Goldman Sachs fireside.
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced new pediatric limb reconstruction innovations that expand treatment options for pediatric and small stature patients. The Company will highlight these advances at the Pediatric Orthopedic Society of North America (POSNA) 2026 Annual Meeting, which takes place May 6-8, 2026, at the Rosen Shingle Creek Hotel in Orlando, Florida. At POSNA 2026, Orthofix will showcas.
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Shareholders are encouraged to contact the firm at no cost or obligation.
Orthofix Medical Inc. (OFIX) Q1 2026 Earnings Call Transcript
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company reaffirmed its full-year 2026 financial guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6™ pr.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Orthofix Medical, Inc. (“Orthofix” or the “Company”) (NasdaqGS: OFIX).On September 12, 2023, the Company announced the appointment of an interim CEO, interim CFO, and interim CLO, effective immediately, following the “unanimous decision by the Board's independent directors.
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing th.
Orthofix Medical Inc. (NASDAQ: OFIX - Get Free Report) insider Jorge Andres Cedron sold 3,743 shares of the business's stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $12.82, for a total transaction of $47,985.26. Following the transaction, the insider owned 59,006 shares in the company, valued at
NEW YORK and NEW ORLEANS, April 17, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.